Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
30.33
+0.91 (3.11%)
Nov 9, 2026, 11:25 AM EST - Market open

Agios Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8141,5871,8741,2451,5431,785
Market Cap Growth
-23.22%-15.30%50.56%-19.32%-13.57%-40.52%
Enterprise Value
933375274448607488
Last Close Price
29.4127.2232.8622.2728.0832.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.78--1.11
Forward PE
-7.847.84---
PS Ratio
12.4929.3851.3546.40108.35-
PB Ratio
1.801.331.221.541.401.38
P/TBV Ratio
1.801.331.221.541.401.38

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.246.937.5116.7042.61-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.040.090.080.08
Net Debt / Equity Ratio
-0.90-0.94-0.96-0.90-0.92-0.92
Net Debt / EBITDA Ratio
2.132.413.511.912.663.22
Net Debt / FCF Ratio
2.622.983.772.473.222.88
Asset Turnover
0.120.040.030.030.01-
Inventory Turnover
10.0811.4313.0821.65--
Quick Ratio
8.5410.5311.0611.4912.5417.17
Current Ratio
9.6911.4611.9012.2713.3017.79
Return on Equity (ROE)
-32.95%-30.20%57.29%-36.83%-19.38%-42.15%
Return on Assets (ROA)
-21.40%-19.93%-20.47%-22.49%-18.17%-20.65%
Return on Invested Capital (ROIC)
-102.84%-87.18%-98.60%-153.69%-100.74%-102.54%
Return on Capital Employed (ROCE)
-42.50%-38.90%-26.90%-45.00%-33.10%-27.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.81%-26.00%35.95%-28.29%-15.02%89.89%
FCF Yield
-19.10%-23.77%-20.89%-23.87%-20.38%-23.14%
Buyback Yield / Dilution
-2.47%-0.14%-4.02%-1.57%9.36%12.39%
SEC Filings: 10-K · 10-Q